Document Classification

Section Type: RESULTS

Text: Valsartan was associated with decreases in the risks of first morbid event (HR, 0. 74 ; 95 % CI, 0. 60 to 0. 91 ; P = 0. 005) and hospitalization for HF (HR, 0. 60 ; 95 % CI, 0. 45 to 0. 79 ; P < 0. 001) in the lowest quartile that were not significantly different than the valsartan effects in the other 3 quartiles combined (first morbid event HR, 0. 90 ; 95 % CI, 0. 79 to 1. 02 ; P = 0. 10 ; and HF hospitalization HR, 0. 77 ; 95 % CI, 0. 64 to 0. 93 ; P = 0. 006 ; nonsignificant interactions).